{
    "id": "medical_genetics-045",
    "question": "The maternal serum level of alpha-fetoprotein (AFP) is lower than average in which situation?",
    "options": {
        "A": "Down syndrome",
        "B": "Exomphalos",
        "C": "Neural tube defects",
        "D": "Twin pregnancies"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents and understand the relationship between maternal serum alpha-fetoprotein (AFP) levels and the given options. Step 1: Reviewing the documents, we know that maternal serum AFP levels are elevated in ectopic pregnancies (Document [0]). However, this is not directly related to the question. Step 2: Document [1] mentions that low levels of AFP are associated with fetal aneuploidy, such as Down syndrome, trisomy 18, and trisomy 13. This suggests that low AFP levels are not directly related to the options. Step 3: Document [2] explains that elevated AFP levels are associated with neural tube defects, such as anencephaly and spina bifida. This implies that low AFP levels are not related to these conditions. Step 4: Document [6] states that low levels of AFP, estriol, \u03b2-hCG, and inhibin A are associated with trisomy 18. However, this is specific to trisomy 18 and does not directly relate to the other options. Step 5: Document [11] mentions that low AFP levels are associated with Down syndrome, but this is not the only condition associated with low AFP levels. Step 6: Document [23] states that low AFP levels are associated with adverse pregnancy outcomes, including fetal growth restriction, preeclampsia, preterm birth, fetal demise, and stillbirth. This is a broad condition that encompasses multiple options. Step 7: Document [26] mentions that low AFP levels are associated with twin pregnancies, as they are generally higher in twins compared to singletons. Step 8: Document [27] provides a table showing that the positive-predictive value of an AFP level is low for Down syndrome, trisomy 21, and other aneuploidies. Step 9: Document [28] mentions that low AFP levels are associated with certain tumors, such as germ cell tumors. Step 10: Document [31] states that low AFP levels are associated with twin pregnancies. Conclusion: Based on the analysis, the correct answer is D. Twin pregnancies, as low AFP levels are generally higher in twins compared to singletons.\"} \"answer_choice\": \"D\"",
    "snippets": [
        {
            "id": "Gynecology_Novak_3177",
            "title": "Gynecology_Novak",
            "content": "Maternal serum \u03b1-fetoprotein (AFP) levels are elevated in ectopic pregnancies; however, the use of AFP measurements as a screening technique for ectopic pregnancy was not studied (131,132). A combination of AFP with three other markers\u2014\u03b2-hCG, progesterone, and estradiol\u2014has 98.5% specificity and 94.5% accuracy for the prediction of ectopic pregnancy (133,134). Serum placental growth factor may prove to be a diagnostic biomarker for ectopic pregnancy because it was shown to be undetectable in ectopic and nonviable pregnancies. C-reactive protein is an acute-phase reactant that increases with trauma or infection. Levels of this protein are lower in patients with ectopic pregnancy than in patients with an acute infectious process. When an infectious process is part of the differential diagnosis, measurement of C-reactive protein may be beneficial (135)."
        },
        {
            "id": "Pediatrics_Nelson_990",
            "title": "Pediatrics_Nelson",
            "content": "Historically, prenatal screening involved maternal serum screening for \u03b1-fetoprotein (AFP), a protein secreted during fetal life by the liver, gastrointestinal tract, and yolk sac. Some of the AFP crosses the placenta and enters the maternal circulation. Although maternal serum screening was initially used to detect high levels of AFP associated with neural tube defects (NTDs) and the disruption of fetal integument such as omphalocele or gastroschisis, low levels of AFP were found to be associated with fetal aneuploidy. Approximately 50% of fetuses with autosomal trisomies (Down syndrome, trisomy 18, trisomy 13) will be detected by low maternal serum AFP levels. Three other proteins\u2014unconjugated estriol (uE3),inhibin A, and human chorionic gonadotropin (HCG)\u2014were added to the maternal serum screening to create the quad screen. The addition of these compounds increased the detection rate to about 80%."
        },
        {
            "id": "Obstentrics_Williams_1870",
            "title": "Obstentrics_Williams",
            "content": "Maternal Serum AFP Elevation: Neural-Tube Defect Screening. All pregnant women are ofered screening for fetal open neural-rube defects in the second trimester, either with MSAFP screening or with sonography (American College of Obstetricians and Gynecologists, 20 16c). Measurement of the MSAFP concentration between 15 and 20 weeks' gestation has been ofered as part of routine prenatal care for more than 30 years. Because AFP is the major protein in fetal serum, analogous to albumin in a child or adult, the normal concentration gradient between fetal plasma and maternal serum is on the order of 50,000: 1. Defects in fetal integument, such as neural-tube and ventral-wall defects, permit AFP to leak into the amnionic fluid, resulting in dramatically increased maternal serum levels. he AFP value rises by about 15 percent per week during the screening window (Knight, 1992). he MoM is generally recalculated if the irst-trimester CRL or second-trimester biparietal diameter difers from the"
        },
        {
            "id": "InternalMed_Harrison_4968",
            "title": "InternalMed_Harrison",
            "content": "Abnormalities on prenatal ultrasound are the second most frequent indication for prenatal genetic screening. Ultrasound screening can reveal structural or functional anomalies in the fetus, which might be associated with chromosome or genomic disorders. Follow-up chromosome studies may therefore be recommended. Maternal serum screening results are the third most frequent indication for prenatal chromosome analysis. There have been several versions of maternal serum screening offered over the past few decades. Currently, the \u201cquad\u201d screen analyzes levels of \u03b1 fetoprotein (AFP), human chorionic gonadotropin (hCG), estriol, and inhibin-A. The values of these analytes are used to adjust the maternal age\u2013predicted risk of a trisomy 21 or trisomy 18 fetus."
        },
        {
            "id": "Obstentrics_Williams_1854",
            "title": "Obstentrics_Williams",
            "content": "Each maternal serum analyte is measured as a concentration-for example, nanograms per milliliter of AFP. he concentration is converted to a multiple of the median (MoM) by adjusting for maternal age, maternal weight, and gestational age. he nuchal translucency measurement increases with crown-rump length (CRL) , and thus its value is adjusted for CRL and also reported as an MoM. The AFP analyte is further adjusted for maternal race and ethnicity and for presence of diabetes, which all afect the calculation of neural-tube defect risk rather than of aneuploidy risk (Greene, 1988; Huttly, 2004). Reporting these results as an MoM of the unafected population normalizes the distribution of analyte levels and permits comparison of results from diferent laboratories and populations."
        },
        {
            "id": "Obstentrics_Williams_1832",
            "title": "Obstentrics_Williams",
            "content": "More than 40 years ago, Brock (1972, 1973) observed that pregnancies complicated by neural-tube defects had higher levels of alpha-fetoprotein (AFP) in maternal serum and amnionic luid. his formed the basis for the irst maternal serum screening test for a fetal condition. The beginning of widespread serum screening came in 1977, after a collaborative trial from the United Kingdom established the association between elevated maternal serum AFP levels (MSAFP) and fetal open neural-tube defects (Wald, 1977). When screening was performed at 16 to 18 weeks' gestation, detection approached 90 percent for pregnancies with fetal anencephaly and 80 percent for those with myelomeningocele (spina biida). hese sensitivities are comparable to current testing (American College of Obstetricians and Gynecologists, 20 16a)."
        },
        {
            "id": "First_Aid_Step2_699",
            "title": "First_Aid_Step2",
            "content": "Get a quantitative \u03b2-hCG: To diagnose and follow ectopic pregnancy. To monitor trophoblastic disease. To screen for fetal aneuploidy. Still UNDERage at 18: trisomy 18 = \u2193 AFP, \u2193 estriol, \u2193\u03b2-hCG, \u2193 inhibin A. Table 2.11-2 outlines a typical prenatal diagnostic testing schedule by week. The sections that follow describe each recommended screening modality in further detail. The standard for diagnosing pregnancy. Produced by the placenta; peaks at 100,000 mIU/mL by 10 weeks of gesta tion. \u25a0\u2193 throughout the second trimester; levels off in the third trimester. hCG levels double approximately every 48 hours during early pregnancy. This is often used to diagnose ectopic pregnancy when doubling is abnormal. Maternal serum \u03b1-fetoprotein (MSAFP), which is produced by the fetus, crosses the placenta in small amounts and enters the maternal circulation. Measurement results are reported as multiples of the median (MoMs) and depend on accurate gestational dating."
        },
        {
            "id": "Obstentrics_Williams_1263",
            "title": "Obstentrics_Williams",
            "content": "Screening for neural-tube defects with maternal serum alpha-fetoprotein (MSAFP) has been ofered routinely as part of prenatal care since the 1980s (Chap. 14, p. 283). Women currently have the option of neural-tube defect screening with MSAFP, sonography, or both (American College of Obstetricians and Gynecologists, 2016). Serum screening is generally performed between 15 and 20 weeks' gestation. And, if using an upper threshold of 2.5 multiples of the median (MoM), the anticipated detection rate is at least 90 percent for fetal anencephaly and 80 percent for myelomeningocele. Targeted sonography is the preferred diagnostic test, and in addition to characterizing the neural-tube defect, it may identiy other abnormalities or conditions that also result in MSAFP elevation (Table 14-6, p. 283)."
        },
        {
            "id": "Obstentrics_Williams_1846",
            "title": "Obstentrics_Williams",
            "content": "Aneuploidy screening can be challenging because the test characteristics of each option may vary with maternal age and with whether the test is analyte-based or cell-free DNA-based. The test sensitivity is the detection rate-that is, the proportion of aneuploid fetuses identiied by the screening test. Its converse, the false-negative rate, is the percentage of cases that the test is expected to miss. A first-trimester screening test with a sensitivity of 80 percent is expected to miss 1 in 5 cases. The sensitivity of screening tests for Down syndrome has increased steadily during the past 30 years, from just 25 percent with serum AFP alone to more than 90 percent with integrated or sequential screening."
        },
        {
            "id": "Obstentrics_Williams_7931",
            "title": "Obstentrics_Williams",
            "content": "Maternal serum alpha-fetoprotein determination at 16 to 20 weeks' gestation is used in association with targeted sonographic examination to detect neural-tube defects and other anomalies (Chap. 14, p. 283). hese levels may be lower in diabetic pregnancies, and interpretation is altered accordingly. Because the incidence of congenital cardiac anomalies is fivefold in mothers with diabetes, fetal echocardiography is an important part of second-trimester sonographic evaluation (Fouda, 2013). Despite advances in ultrasound technology, however, Dashe and associates (2009) cautioned that detection of fetal anomalies in obese diabetic women is more diicult than in similarly sized women without diabetes."
        },
        {
            "id": "Obstentrics_Williams_1873",
            "title": "Obstentrics_Williams",
            "content": "Virtually all cases of anencephaly and many cases of spina biida may be detected or suspected during a standard second-trimester sonographic examination (Dashe, 2006). Most centers now use targeted sonography as the primary method to evaluate elevated MSAFP levels and as the prenatal diagnostic test of choice for neural-tube defects (Chap. 10, p. 192). If targeted sonography is not available and myelomeningocele cannot be excluded, amniocentesis may be considered for measurement of amnionic luid AFP and acetylcholinesterase levels. That said, we recommend additional imaging prior to establishing the diagnosis, with the understanding that other TABLE 14-6. Conditions Associated with an Elevated MSAFP Concentration Renal anomalies-polycystic kidneys, renal agenesis, congenital nephrosis, urinary tract obstruction Chorioangioma of placenta MSAFP = maternal serum alpha-fetoprotein."
        },
        {
            "id": "Surgery_Schwartz_2241",
            "title": "Surgery_Schwartz",
            "content": "adjuvant therapy; the data are stronger for the use of CEA for monitoring for postoperative recurrence.111 CEA measurement is the most cost-effective approach for detecting metastasis, with over 60% of recurrences being detected first by an elevation in CEA level. Therefore, in cases in which the patient would be a candidate for resection of recurrent colorectal cancer or systemic therapy, the ASCO guidelines recommend that postoperative CEA testing be performed every 3 months in patients with stage II or III disease for at least 3 years.112 CEA is the marker of choice for monitor-ing metastatic colorectal cancer during systemic therapy.112Alpha-Fetoprotein. Alpha-fetoprotein (AFP) is a glycoprotein normally produced by a developing fetus. AFP levels decrease soon after birth in healthy adults. An elevated level of AFP sug-gests the presence of either primary liver cancer or a germ cell tumor of the ovary or testicle. Rarely, other types of cancer such as gastric are associated with"
        },
        {
            "id": "Surgery_Schwartz_4891",
            "title": "Surgery_Schwartz",
            "content": "PET is useful for distinguishing malignant from benign tumors and may help detect distant metastases in some patients. However, the role of routine PET imaging for staging surgically resectable lesions of the mediastinum has not been established.The use of serum markers to evaluate a mediastinal mass can be invaluable in some patients. For example, nonsemino-matous and seminomatous germ cell tumors can frequently be diagnosed and often distinguished from one another by the lev-els of \u03b1-fetoprotein (AFP) and human chorionic gonadotropin (hCG). In over 90% of nonseminomatous germ cell tumors, either the AFP or the hCG level will be elevated. Results are close to 100% specific if the level of either AFP or hCG is greater than 500 ng/mL. Some centers institute chemotherapy based on this result alone, without biopsy confirmation of the diagnosis. In contrast, the AFP level in patients with mediastinal seminoma is always normal; only 10% will have elevated hCG, which is usually less than"
        },
        {
            "id": "Obstentrics_Williams_5330",
            "title": "Obstentrics_Williams",
            "content": "With abruption, some degree of intravascular coagulation is almost universal. hus, elevated serum levels of D-dimers may be suggestive, but this has not been adequately tested. Preliminary data show that serum alpha-fetoprotein levels > 280 \ufffdg/L have a positive-predictive value of 97 percent (Ngai, 2012)."
        },
        {
            "id": "Obstentrics_Williams_1977",
            "title": "Obstentrics_Williams",
            "content": "Ghidini A, Sepulveda W, Lockwood CJ, et l: Complications of fetal blood sampling. Am J Obstet GynecoIo168(5):1339, 1993 Gil MM, Quezada MS, Revello R, et al: Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet GynecoIo45(3):249, 2015 Goetzl L, Krantz 0, Simpson JL, et al: Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol 104(1):30,o2004 Grati FR, Malvestiti F, Ferreira JC, et al: Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 16(8):620,o2014 Greene MF, Haddow JE, Palomaki GE, et al: Maternal serum alpha-fetoprotein levels in diabetic pregnancies. Lancet 2(8606):345, 1988"
        },
        {
            "id": "Gynecology_Novak_7398",
            "title": "Gynecology_Novak",
            "content": "Most EST lesions secrete AFP and, rarely, they may elaborate detectable alpha-1 antitrypsin (AAT). AFP can be demonstrated in the tumor by means of the immunoperoxidase technique. There is a good correlation between the extent of disease and the level of AFP, although discordance is observed. The serum level of these markers, particularly AFP, is useful in monitoring the patient\u2019s response to treatment (405\u2013409). Figure 37.22 Endodermal sinus tumor of the ovary. Note the classic Schiller-Duval body with its central vessel and mantle of endoderm. Rare Germ Cell Tumors of the Ovary"
        },
        {
            "id": "Obstentrics_Williams_1974",
            "title": "Obstentrics_Williams",
            "content": "DiMaio MS, Baumgarten A, Greenstein RM, et al: Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. N Engl J Med 317(6):342,o1987 Dolk H, Loane M, Garne E: The prevalence of congenital anomalies in Europe. Adv Exp Med Bioi 686:349, 2010 Doody KJ: Treatment of the infertile couple. Hofman BL, Schorge JO, Bradshaw KD, et al (eds): Williams Gynecology, 3rd ed. New York, McGrawHill Education, 20o16 Drumm ML, Konstan MW, Schluchter MD, et al: Genetic modiiers of lung disease in cystic ibrosis. N Engl J Med 353(14):1443, 2005 Dugof L, Hobbins JC, Malone FD, et al: First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropic concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FaSTER Trial). Am J Obstet Gynecol 191(6):1446, 2004"
        },
        {
            "id": "Obstentrics_Williams_1981",
            "title": "Obstentrics_Williams",
            "content": "Knight GK, Palomaki GE: Maternal serum alpha-fetoprotein and the detection of open neural tube defects. In Elias S, Simpson JL (eds): Maternal Serum Screening. New York, Churchill Livingstone, 1992 Kuliev A, Jackson L, Frosrer U, et al: Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel Aviv, Israel, May 21, 1994. Am J Obstet Gynecolo1 4(3):807, 1996 Kuliev A, Rechitsky S: Polar body-based pre implantation genetic diagnosis for Mendelian disorders. Mol Hum Reprod 17(5):275, 2011 Kuppermann M, Pena S, Bishop JT, et al: Efect of enhanced information, values clariication, and removal of inancial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA 312(12):1210,o2014"
        },
        {
            "id": "Obstentrics_Williams_5985",
            "title": "Obstentrics_Williams",
            "content": "Second-trimester analytes, including elevated alpha-fetoprotein and inhibin A levels and low unconjugated serum estriol concentrations, are significantly associated with birthweight below the 5th percentile. An even greater risk of poor growth is linked with certain combinations of these analytes. Still, these markers are poor screening tools for complications such as fetalgrowth restriction due to low sensitivity and positive-predictive values (Dugof, 2010). Nuchal translucency is also not predictive of fetal-growth restriction. he role of all these markers in aneuploidy screening is discussed in Chapter 14 (p. 281)."
        },
        {
            "id": "Obstentrics_Williams_1903",
            "title": "Obstentrics_Williams",
            "content": "E. Clinodactyly-hypoplasia of the 5th finger middle phalanx creates an inward curvature (arrow). F. \"Sandal-gap\" (arrow). 0.5 percent of pregnancies and most commonly represents small amounts of swallowed blood, frequently in the setting of maternal serum AFP level elevation. Although typically associated with normal outcomes, it raises the risk for Down syndrome approximately sixfold. Echogenic bowel has also been associated with fetal cytomegalovirus infection and cystic ibrosisrepresenting inspissated meconium in the latter."
        },
        {
            "id": "Pathology_Robbins_1452",
            "title": "Pathology_Robbins",
            "content": "Like PSA, CEA and AFP can be elevated in a variety of non-neoplastic conditions and thus also lack the specificity and sensitivity required for the early detection of cancers, but they may be useful in monitoring disease once the diagnosis is established. With successful resection of the tumor, these markers disappear from the serum; their reappearance almost always signifies recurrence. CEA is further discussed in Chapter 15 and alpha fetoprotein in Chapter 16."
        },
        {
            "id": "Obstentrics_Williams_871",
            "title": "Obstentrics_Williams",
            "content": "Liver enzymes and other plasma proteins are produced by the fetus, and these levels do not correlate with maternal levels (Weiner, 1992). Concentrations of plasma proteins, which include albumin, lactic dehydrogenase, aspartate aminotransferase, 1-glutamyl transpeptidase, and alanine transferase, all rise. Conversely, prealbumin levels decline with gestational age (Fryer, 1993). At birth, mean total plasma protein and albumin concentrations in fetal blood are similar to maternal levels. This is important because albumin binds unconjugated bilirubin to prevent kernicterus in the newborn (Chap. 33, p. 626)."
        },
        {
            "id": "Obstentrics_Williams_1968",
            "title": "Obstentrics_Williams",
            "content": "Brock OJ, Bolton E,Monaghan JM: Prenatal diagnosis of anencephaly through maternal serum-alpha-fetoprotein measurement. Lancet 2(7835):923, 1973 Brock OJ, Sutclife RG: Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 2(7770):197, 1972 Bromley B, Lieberman E, Shipp TO, et al: he genetic sonogram, a method for risk assessment for Down syndrome in the mid trimester. J Ultrasound Med 21(10):1087,o2002 Bush MC, Malone FD: Down syndrome screening in twins. Clin Perinatol 32(2):373, 2005 Cahill AG, Macones GA, Stamilio OM, et al: Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol 200(3):257.e1,o2009 Callaway JL, Shafer LG, Chitty LS, et al: he clinical utility of micro array technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn 33(12): 1119,o2013 Canadian Early and Mid-Trimester Amniocentesis Trial (CEMAT) Group:"
        },
        {
            "id": "Obstentrics_Williams_1875",
            "title": "Obstentrics_Williams",
            "content": "Unexplained Abnormalities of Second-Trimester Analytes. he positive-predictive value of an elevated MSAFP value is only 2 percent. Approximately 98 percent of pregnancies with an MSAFP level exceeding 2.5 MoM have an etiology other than a neural-tube defect. hus, counseling is indicated not only to inform the patient about the beneits and limitations of targeted sonography for the diagnosis of neural-tube defects but also to review the numerous other conditions. Some of these include fetal anomalies, placental abnormalities, and adverse outcomes associated with MSAFP level elevation (see Table 14-6). he likelihood of one of these abnormalities or of an adverse pregnancy outcome in the absence of a recognized abnormality rises in proportion to the AFP level. Adverse outcomes include fetal-growth restriction, preeclampsia, preterm birth, fetal demise, and stillbirth. More than 40 percent of pregnancies may be abnormal if the MSAFP level is greater than 7 MoM (Reichler, 1994)."
        },
        {
            "id": "Obstentrics_Williams_1980",
            "title": "Obstentrics_Williams",
            "content": "Jellife-Pawlowski LL, Baer R, Blumenfeld j, et al: laternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth. BJOG 122(11):1484,o2015 Kaback M, Lim-Steele J, Dabholkar 0, et al: Tay Sachs disease: carrier screening, prenatal diagnosis, and the molecular era. JAMA 270:2307, 1993 Kazerouni NN, Currier RJ, Flessel M, et al: Detection rate of quadruplemarker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. Prenat Diagn 31(9):901,o2011 Knight GK, Palomaki GE: Maternal serum alpha-fetoprotein and the detection of open neural tube defects. In Elias S, Simpson JL (eds): Maternal Serum Screening. New York, Churchill Livingstone, 1992"
        },
        {
            "id": "Obstentrics_Williams_1975",
            "title": "Obstentrics_Williams",
            "content": "DugofL, Hobbins JC, Malone FD, et al: Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106(2):260, 2005 Dugof L, Sociery for Maternal-Fetal Medicine: First-and second-trimester maternal serum markers for aneuploidy and adverse pregnancy outcomes. Obstet GynecoIo115(5):1052, 2010 Ecker JL, Shipp TD, Bromley B, et al: The sonographic diagnosis of DandyWalker and Dandy-Walker variant: associated indings and outcomes. Prenat Diagn 20(3):328, 2000 Evans MI, Wapner RJ: Invasive prenatal diagnostic procedures. Semin PerinatoIo29(4):215,o2005 Filly A, Callen PW, Goldstein RB: Alpha-fetoprotein screening programs: what every obstetric sonologist should know. Radiology 188(1):1, 1993 Firth HV, Boyd PA, Chamberlain PF, et al: Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 343(8905): 1069, 1994"
        },
        {
            "id": "Obstentrics_Williams_6119",
            "title": "Obstentrics_Williams",
            "content": "Although not typically used to diagnose multifetal pregnancy, magnetic resonance (MR) imaging may help delineate complications in monochorionic twins (Hu, 2006). In one review of 17 complicated twin gestations evaluated by both sonographic and MR imaging, the latter provided a more detailed assessment of twin pathology (Bekiesinska-Figatowska, 2013). This was particularly helpful in cases of conjoined twins. No biochemical test reliably identifies multifetal gestations. Serum and urine levels of 3-hCG and maternal serum levels of alpha-fetoprotein (MSAFP) are generally higher with twins compared with those in singletons. However, levels may vary considerably and overlap with those of singletons."
        },
        {
            "id": "Obstentrics_Williams_1851",
            "title": "Obstentrics_Williams",
            "content": "Modified with permission from Dashe JS: Aneuploidy screening in pregnancy, Obstet Gynecol. 2016 Jul;128(1 ):181l-194. as a l:X ratio or as a percentage. he positive-predictive value value reported in a research trial is the proportion of women is directly afected by disease prevalence, so it is much higher with positive screening results who have afected fetuses for women aged 35 years and older than for younger women (see Table 14-4). Negative-predictive value is the proportion of (Table 14-5). Positive-predictive values can also be reported those with a negative screening test result who have unafected for cohorts of pregnancies. For example, the positive-predictive (euploid) fetuses. Because the prevalence of aneuploidy is so TABLE 14-4. Characteristics of Screening Tests for Trisomy 21 in Singletons Screening Test Rate Rate Predictive Valuea Quadruple screen: AFP, hCG, estriol, inhibin 80-82% 5% 3% First-trimester screen: NT, hCG, PAPP-A 80-84% 5% 3-4%"
        },
        {
            "id": "InternalMed_Harrison_7545",
            "title": "InternalMed_Harrison",
            "content": "also have a proclivity for hemorrhage, sometimes with catastrophic complications. Chemotherapy is occasionally effective, and women tend to receive regimens designed to treat epithelial or germ cell tumors. Bevacizumab has some activity in clinical trials but is not approved for this specific indication. These tumors often produce high levels of m\u00fcllerian inhibiting substance (MIS), inhibin, and, in the case of Sertoli-Leydig tumors, \u03b1 fetoprotein (AFP). These proteins are detectable in serum and can be used as tumor markers to monitor women for recurrent disease because the increase or decrease of these proteins in the serum tends to reflect the changing bulk of systemic tumor."
        },
        {
            "id": "InternalMed_Harrison_7493",
            "title": "InternalMed_Harrison",
            "content": "Careful monitoring of the serum tumor markers AFP and hCG is essential in the management of patients with GCT, because these markers are important for diagnosis, as prognostic indicators, in monitoring treatment response, and in the early detection of relapse. Approximately 70% of patients presenting with disseminated nonseminomatous GCT have increased serum concentrations of AFP and/or hCG. Although hCG concentrations may be increased in patients with either nonseminoma or seminoma histology, the AFP concentration is increased only in patients with nonseminoma. The presence of an increased AFP level in a patient whose tumor shows only seminoma indicates that an occult nonseminomatous component exists, and the patient should be treated for nonseminomatous GCT. LDH levels are less specific than AFP or hCG but are increased in 50\u201360% patients with metastatic nonseminoma and in up to 80% of patients with advanced seminoma."
        },
        {
            "id": "Obstentrics_Williams_7686",
            "title": "Obstentrics_Williams",
            "content": "Normal values for concentrations of many cellular elements during pregnancy are listed in the Appendix (p. 1255). The Centers for Disease Control and Prevention (1998) deined anemia in iron-supplemented pregnant women using a cutof of the 5th percentile-lrl g/dL in the irst and third trimesters, and 10.5 g/dL in the second trimester (Fig. he modest fall in hemoglobin levels and hematocrit values during pregnancy is caused by a relatively greater expansion of plasma volume compared with the increase in red cell volume. he disproportion between the rates at which plasma and erythrocytes are added to the maternal circulation is greatest during the second trimester. Late in pregnancy, plasma expansion essentially ceases, while hemoglobin mass continues to accrue."
        },
        {
            "id": "Obstentrics_Williams_1866",
            "title": "Obstentrics_Williams",
            "content": "Currently, the only second-trimester multiple marker test widely used in the United States is the quadruple marker or \"quad\" screening test. It is performed from 15 to 21 weeks' gestation, and inclusive gestational age ranges vary according to individual laboratories. Pregnancies with fetal Down syndrome are characterized by lower maternal serum AFP, higher hCG, lower unconjugated estriol, and higher dimeric inhibin levels. When the quad screen was initially described, the Down syndrome detection rate approximated 70 percent. But, by the early 2000s, the reported detection rate in two large prospective trials had improved to 81 to 83 percent, with a 5-percent screen-positive rate (Malone, 2005b; Wald, 1996, 2003). The improved detection rate is attributable, at least in part, to accurate gestational age assessment with sonography. In a review of more than 500,000 pregnancies receiving quadruple-marker screening through the statewide California Prenatal Screening Program, trisomy 21"
        }
    ],
    "scores": [
        0.03921757110034248,
        0.03865535956093373,
        0.037813728449020506,
        0.03714109272357498,
        0.036344856651023695,
        0.035473850415344566,
        0.03474185026786647,
        0.03164450686542685,
        0.03090140544341699,
        0.026804035789205895,
        0.026227585051114465,
        0.0243807717491928,
        0.023706756427904003,
        0.023224852071005917,
        0.02287168302435478,
        0.022632188073364545,
        0.02174068829019434,
        0.02161916366461821,
        0.021504810978495187,
        0.021124146814330863,
        0.02078558973720264,
        0.020723270440251573,
        0.019789183728777443,
        0.01942992194430911,
        0.0193554431133964,
        0.017605245087313835,
        0.017105263157894735,
        0.01627737709256931,
        0.016050333846944015,
        0.015914786967418545,
        0.015864128406121687,
        0.01552757793764988
    ],
    "execution_time": 36.7574827671051
}